Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02552 HUA MEDICINE-B
RT Nominal up1.390 +0.070 (+5.303%)
Latest  |  Final  |  Interim
Non-current Assets
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others39,939-11.928%45,34853,85557,94249,341
Land & other Lease Assets61,387-11.278%69,19085,85398,65874,177
Intangible Assets27,530-3.647%28,57231,9529,0263,387
Interests in Asso. & JCEs0--0000
Other Non-current Assets9,745-0.419%9,7869,58033,32726,339

138,601-9.349%152,896181,240198,953153,244
Current Assets
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Inventories73,23364.071%44,6351,91500
Trade Receivables49,7837715.228%63711,12100
Cash & Bank Balances1,338,809-8.352%1,460,824490,632675,2381,032,090
Other Current Assets54,359-18.111%66,381436,58929,36213,187
Assets Held for Sale0--0000

1,516,184-3.580%1,572,477940,257704,6001,045,277
Current Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Trade Payables89,75773.836%51,63320,98223,78525,821
S-T Debt & Leases92,229122.394%41,47155,41313,29611,503
Other Current Liabilities129,090-18.776%158,930111,99169,80369,223
Liab asso w/ Assets Held for Sale0--0000

311,07623.426%252,034188,386106,884106,547
Net Current Assets1,205,108-8.735%1,320,443751,871597,716938,730
Total Assets Less Current Liabilities1,343,709-8.798%1,473,339933,111796,6691,091,974
Non-current Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
L-T Debt & Leases180,18542.683%126,28342,16958,23269,212
Other Non-current Liabilities1,196,695-3.950%1,245,905611,362288,106290,267

1,376,8800.342%1,372,188653,531346,338359,479
Capital and Reserves
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
  Share Capital7,2140.000%7,2147,2147,2117,209
  Reserves(40,385)--93,937272,366443,120725,286
  Others0--0000
Shareholders' Funds(33,171)--101,151279,580450,331732,495
Non-controlling Interests0--0000
Others0--0000

(33,171)--101,151279,580450,331732,495
Commitments and Contingent Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Commitments----3,1861,1074,3810
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 27/11/2024 11:56
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (¥)RMB -142,241,000
%Change57.877%
EPS / (LPS)RMB -0.150
NBV Per Share (¥)RMB -0.031
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.